USD10
ETON Anteile
Über Eton PharmaceuticalsEton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
USD10
ETON Anteile
Über Eton PharmaceuticalsEton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Statistiken
TRADINGFENSTER
Geschlossen
ÖFFNET AM
Nicht genügend Daten
MARKTKAPITALISIERUNG
603,39 Mio. $
ERÖFFNUNGSPREIS
21,40 $
TIEF (1 J)
11,09 $
HOCH (1 J)
23,00 $
TIEF (24 STD.)
20,42 $
HOCH (24 STD.)
22,97 $
VOLUMEN (24 STD.)
897.010,20 $
21,85 %
Kursverlauf
Time | Price | Change |
|---|---|---|
Heute | 21,40 $ | |
1 Tag | 22,32 $ | |
1 Woche | 19,50 $ | |
1 Monat | 19,79 $ | |
1 Jahr | 14,79 $ |